Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 1, 2011

Primary Completion Date

May 25, 2012

Study Completion Date

May 25, 2012

Conditions
Eyelash Hypotrichosis
Interventions
DRUG

bimatoprost solution 0.03%

One drop of bimatoprost solution 0.03% applied along each upper eyelid margin once daily in the evening for 4 months.

DRUG

bimatoprost vehicle solution

One drop of bimatoprost vehicle solution applied along each upper eyelid margin once daily in the evening for 4 months.

Trial Locations (1)

Unknown

Chiba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY